Literature DB >> 33791977

Microbial Metabolomics: From Methods to Translational Applications.

Rui Guo1, Xialin Luo1, Xu Xin1,2, Lian Liu3, Xijun Wang2, Haitao Lu4.   

Abstract

Most microbe-associated infectious diseases severely affect human health. However, clinical diagnosis of pathogenic diseases remains challenging due to the lack of specific and highly reliable methods. To better understand the diagnosis, pathogenesis, and treatment of these diseases, systems biology-driven metabolomics goes beyond the annotated phenotype and better targets the functions than conventional approaches. As a novel strategy for analysis of metabolomes in microbes, microbial metabolomics has been recently used to study many diseases, such as obesity, urinary tract infection (UTI), and hepatitis C. In this chapter, we attempt to introduce various microbial metabolomics methods to better interpret the microbial metabolism underlying a diversity of infectious diseases and inspire scientists to pay more attention to microbial metabolomics, enabling broadly and efficiently its translational applications to infectious diseases, from molecular diagnosis to therapeutic discovery.

Entities:  

Keywords:  Infectious diseases; Mass spectrometry; Method development; Microbial metabolomics; Translational applications

Mesh:

Year:  2021        PMID: 33791977     DOI: 10.1007/978-3-030-51652-9_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  48 in total

1.  Myxoprincomide: a natural product from Myxococcus xanthus discovered by comprehensive analysis of the secondary metabolome.

Authors:  Niña Socorro Cortina; Daniel Krug; Alberto Plaza; Ole Revermann; Rolf Müller
Journal:  Angew Chem Int Ed Engl       Date:  2011-12-07       Impact factor: 15.336

Review 2.  Microbial metabolomics: past, present and future methodologies.

Authors:  Mlawule R Mashego; Karl Rumbold; Marjan De Mey; Erick Vandamme; Wim Soetaert; Joseph J Heijnen
Journal:  Biotechnol Lett       Date:  2006-11-08       Impact factor: 2.461

Review 3.  Separation and mass spectrometry in microbial metabolomics.

Authors:  David E Garcia; Edward E Baidoo; Peter I Benke; Francesco Pingitore; Yinjie J Tang; Sandra Villa; Jay D Keasling
Journal:  Curr Opin Microbiol       Date:  2008-06-04       Impact factor: 7.934

4.  Sampling methods for NMR-based metabolomics of Staphylococcus aureus.

Authors:  Xiao-He Wu; Hai-Long Yu; Zhao-Yong Ba; Jing-Yu Chen; Hong-Gang Sun; Bei-Zhong Han
Journal:  Biotechnol J       Date:  2010-01       Impact factor: 4.677

5.  A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics.

Authors:  Andrew D Southam; Ralf J M Weber; Jasper Engel; Martin R Jones; Mark R Viant
Journal:  Nat Protoc       Date:  2017-01-12       Impact factor: 13.491

6.  Approaches to Sample Size Determination for Multivariate Data: Applications to PCA and PLS-DA of Omics Data.

Authors:  Edoardo Saccenti; Marieke E Timmerman
Journal:  J Proteome Res       Date:  2016-07-07       Impact factor: 4.466

7.  A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice.

Authors:  A Marcobal; P C Kashyap; T A Nelson; P A Aronov; M S Donia; A Spormann; M A Fischbach; J L Sonnenburg
Journal:  ISME J       Date:  2013-06-06       Impact factor: 10.302

8.  Microbial metabolomics with gas chromatography/mass spectrometry.

Authors:  Maud M Koek; Bas Muilwijk; Mariët J van der Werf; Thomas Hankemeier
Journal:  Anal Chem       Date:  2006-02-15       Impact factor: 6.986

9.  1H NMR-based spectroscopy detects metabolic alterations in serum of patients with early-stage ulcerative colitis.

Authors:  Ying Zhang; Lianjie Lin; Yanbin Xu; Yan Lin; Yu Jin; Changqing Zheng
Journal:  Biochem Biophys Res Commun       Date:  2013-03-16       Impact factor: 3.575

Review 10.  The role of metabolites and metabolomics in clinically applicable biomarkers of disease.

Authors:  Mamas Mamas; Warwick B Dunn; Ludwig Neyses; Royston Goodacre
Journal:  Arch Toxicol       Date:  2010-10-16       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.